Boomi CEO Steve Lucas’ New Book ‘Digital Impact’ Becomes a National Bestseller, Topping USA Today andPublishersWeekly Lists
“Digital Impact: The Human Element of AI-Driven Transformation” earns top rankings as business leaders embrace its timely message on the responsible use of AI
Boomi™, the intelligent integration and automation leader, today announced that Chairman and CEO Steve Lucas is now a national bestselling author with the release of his new book, Digital Impact: The Human Element of AI-Driven Transformation (Wiley). Since its debut, the book has rapidly climbed national bestseller charts — including multiple appearances on USA TODAY’s Bestselling Books lists, and Publishers Weekly Bestseller List. Digital Impact resonates deeply with business leaders navigating the intersection of AI and human-centered innovation, offering a timely blueprint for more thoughtful, effective digital transformation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250429280721/en/
Boomi CEO Steve Lucas’ New Book ‘Digital Impact’ Becomes a National Bestseller, Topping USA Today and Publishers Weekly Lists
With AI continuing to dominate executive agendas, Digital Impact offers a fresh perspective — one that emphasizes empathy, trust, and responsibility alongside innovation and speed. Lucas draws on decades of leadership experience to deliver an actionable roadmap for organizations looking to unlock the value of AI while staying grounded in human values.
“Becoming a national bestseller is an incredible honor, but more importantly, it shows how urgent and universal this conversation has become,” Lucas said. “AI is transforming business at an unprecedented pace. Digital Impact is a call to action for leaders to ensure that transformation is guided by purpose, ethics, and a focus on people.”
Following its recent debut, Digital Impact has achieved remarkable early momentum across national bestseller lists, including:
- #11 on USA TODAY’s Bestselling Book List (Overall)
Digital Impact made a stunning debut, ranking #11 across all categories on USA TODAY’s national Bestselling Book List — an incredible achievement that reflects the book’s broad appeal beyond just the business and tech world.
- #5 on USA TODAY’s Bestselling List for Nonfiction
Among all nonfiction titles, Digital Impact entered the charts at #5, positioned alongside some of the most influential thought leadership and current affairs titles in the country.
- #3 on USA TODAY’s Bestselling List for Business Books
The book secured the #3 spot among business books, underscoring its relevance for today’s leaders looking to understand and navigate AI-driven transformation with a human-first mindset.
- #18 on Publishers Weekly Hardcover Nonfiction Bestseller List
In its first week of eligibility, Digital Impact also made its debut at #18 on Publishers Weekly’s Hardcover Nonfiction Bestseller List, a trusted benchmark for the publishing industry that reflects strong sales performance and national traction.
Early praise for the book highlights its relevance in today’s AI-driven world, with executives, CIOs, and tech influencers citing Digital Impact as a must-read for anyone navigating digital change.
The book is now available at major retailers, including Amazon, Barnes & Noble, and Books-A-Million.
To learn more, visit: boomi.com/digitalimpact
About Boomi
Boomi, the intelligent integration and automation leader, helps organizations around the world automate and streamline critical processes to achieve business outcomes faster. Harnessing advanced AI capabilities, the Boomi Enterprise Platform seamlessly connects systems and manages data flows with API management, integration, data management, and AI orchestration in one comprehensive solution. With over 23,000 customers globally and a rapidly expanding network of 800+ partners, Boomi is revolutionizing the way enterprises of all sizes achieve business agility and operational excellence. Discover more at boomi.com.
© 2025 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250429280721/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Logitech Announces Q4 and Full Fiscal Year 2025 Results29.4.2025 22:03:00 CEST | Press release
A Year of Broad-Based Sales Growth, Expanded Market Share and Increased Profitability, Driven by Strategic Priorities SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the fourth quarter and full Fiscal Year 2025 ended March 31, 2025. For Fiscal Year 2025: Sales were $4.55 billion, up 6 percent in US dollars and 7 percent in constant currency, compared to the prior year. GAAP operating income was $655 million, up 11 percent compared to the prior year. Non-GAAP operating income was $775 million, up 11 percent compared to the prior year. GAAP earnings per share (EPS) was $4.13, up 7 percent compared to the prior year. Non-GAAP EPS was $4.84, up 14 percent compared to the prior year. Cash flow from operations was $843 million. The year-ending cash balance was $1.5 billion. The Company returned $797 million of cash to shareholders through its annual dividend payment and share repurchases.
U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene29.4.2025 21:32:00 CEST | Press release
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the U.S. Patent and Trademark Office (USPTO) rendered a Final Written Decision invalidating all claims of Pharmacyclics LLC’s (Pharmacyclics) U.S. Patent No. 11,672,803 (the ‘803 patent) that were challenged by BeiGene in a post-grant review (PGR) proceeding. On November 1, 2023, BeiGene filed a PGR petition with the USPTO challenging the validity of certain claims of the ‘803 patent, in response to a patent infringement lawsuit Pharmacyclics brought against BeiGene concerning BRUKINSA® (zanubrutinib). On May 1, 2024, the USPTO granted BeiGene’s petition to institute the PGR. The USPTO’s Final Written Decision is appealable by Pharmacyclics. Commenting on the ruling, BeiGene General Counsel Chan Lee said: “We are pleased that the USPTO invalidated all challenged claims of the ‘803 patent. Today’s decision reinforces our belief th
One out of Three Secure Civil IDs Delivered Each Year Is Powered by Thales29.4.2025 16:50:00 CEST | Press release
In a world where identity fraud represents a critical vulnerability for citizens and societies, Thales is leading the transformation of civil identity into a secure and citizen-first service. Through its advanced Civil Identity Suite, Thales enables governments worldwide to protect their citizens, ensuring protection at every stage of the identity journey and for the entire identity chain. Supporting more than 300 national identity programmes and having enrolled over 500 million people, Thales is uniquely positioned to deliver secure and responsible identity solutions. Each year, Thales powers one in three smart civil IDs (official electronic documents) issued worldwide, highlighting the company’s key role in shaping the future of identities and helping governments and citizens transition smoothly to digital. With its Civil Identity Suite, Thalesenables the issuance and management of both physical and digital identities, as well as all means of enrolling citizens and enabling seamless
Solving Border Control Staffing Challenges: Regula Launches an Ecosystem for Remote Document Examination29.4.2025 15:00:00 CEST | Press release
Regula, a global developer of forensic devices and identity verification solutions, introduces an innovative solution designed to transform document examination processes, particularly in border control operations. Based on high-resolution photospectral scanners from the Regula 88XX product line, it enables highly accurate and reliable remote document authentication, effectively addressing the pressing issue of staffing shortages in border security. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250429852027/en/ High-resolution photospectral scanner Regula 8880 for remote document verification (Photo: Regula) Traditionally, document authenticity experts needed to be physically present at each checkpoint. However, this requirement has become increasingly challenging due to current staffing constraints. For example, a recent European Commission report highlights gaps in the availability of certain specialized experts, notably
KnowBe4 Appoints Bryan Palma as President and CEO29.4.2025 15:00:00 CEST | Press release
Founder Stu Sjouwerman Named Executive Chairman KnowBe4, the world-renowned cybersecurity platform that comprehensively addresses human risk management, announced that cybersecurity industry veteran Bryan Palma has been appointed president and chief executive officer of KnowBe4, effective May 5. KnowBe4’s founder and current chief executive officer Stu Sjouwerman has transitioned to the role of executive chairman. Palma is a highly regarded technology executive with over twenty-five years of experience and a proven track record of scaling global technology enterprises by driving profitable growth, improving customer experience, and delivering operational agility. Most recently, he was the chief executive officer of Trellix, a multi-billion dollar cybersecurity market leader formed through the merger of FireEye and McAfee Enterprise. Prior to joining Trellix, he guided some of the world’s leading organizations through pivotal technology and business transformations including Cisco, Boei
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom